Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03488238 · ClinicalTrials.gov registry record
Correlation of Changes in PaO2 and ORi in Adult Patients
A clinical trial, sponsored by Masimo Corporation.
- Completed
- Registry status
- 31
- Enrollment target
NCT03488238 is a clinical trial that has completed, run by Masimo Corporation. The registered enrollment target is 31 participants.
The verdict
NCT03488238 has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above. This is a prospective, non-blinded, non-randomized study of the Oxygen Reserve Index (ORi) in a clinical setting. It is designed to evaluate the correlations with ORi and changes in PaO2 and the potential use of ORi as an early warning of impending arterial oxygen desaturation.
Interventions
- DEVICE ORi sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2018-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03488238
The ClinicalTrials.gov registry entry for NCT03488238 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ORi sensor is the first listed.
NCT03488238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03488238 about?
NCT03488238 is a clinical study titled "Correlation of Changes in PaO2 and ORi in Adult Patients". The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2...
What is the current status of trial NCT03488238?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-08-01. Estimated completion is 2018-09-19.
What interventions are being tested in trial NCT03488238?
The interventions under investigation include: ORi sensor (DEVICE).
Who is sponsoring clinical trial NCT03488238?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.